Antibody to ovalbumin and delayed-type hypersensitivity to Candida albicans and mycobacteria in lactating Holstein cows using Quil A or Freund's complete adjuvant

Veterinary Immunology and Immunopathology

Volumn 127, Issue 3-4, 2009, Pages 220-227

  Heriazon, Armando ^a   Thompson, Kathleen A ^a   Wilkie, Bruce N ^a   Mathes Sears, William ^a   Quinton, Margaret ^b   Mallard, Bonnie A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

Antibody; Candida albicans; Dairy cows; Delayed type hypersensitivity; Immune response; Immunoglobulin G isotypes; Mycobacteria; Quil A

Indexed keywords

ANTIBODY; CELL EXTRACT; EGG WHITE; FREUND ADJUVANT; IMMUNOGLOBULIN G; LYSOZYME; OVALBUMIN; QUIL A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BREEDING; CANDIDA ALBICANS; CELLULAR IMMUNITY; CONTROLLED STUDY; COW; DELAYED HYPERSENSITIVITY; DIAGNOSTIC TEST; FEMALE; IMMUNE RESPONSE; LACTATION; MYCOBACTERIUM; MYCOBACTERIUM PHLEI; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN PURIFICATION; QUANTITATIVE TRAIT; STATISTICAL SIGNIFICANCE; TUBERCULOSIS; WHOLE CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CANDIDA ALBICANS; CATTLE; FEMALE; FREUND'S ADJUVANT; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN G; LACTATION; MYCOBACTERIUM TUBERCULOSIS; OVALBUMIN; SAPONINS; TRANSCRIPTION FACTORS;

ANIMALIA; BOS; CANDIDA ALBICANS; CORYNEBACTERINEAE; MYCOBACTERIUM TUBERCULOSIS;

EID: 58249116534     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.10.002     Document Type: Article

References (43)

1. Allison A.C. The mode of action of immunological adjuvants. Dev. Biol. Stand. 92 (1998) 3-11
2. Baldridge J.R., and Ward J.R. Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity. Vaccine 15 4 (1997) 395-401
3. Bender J.B., Hueston W., and Osterholm M. Recent animal disease outbreaks and their impact on human populations. J. Agromed. 11 1 (2006) 5-15
4. Black A.C. Delayed type hypersensitivity: current theories with an historic perspective. Dermatol. Online J. 5 1 (1999) 7
5. Buddle B.M., de Lisle G.W., Pfeffer A., and Aldwell F.E. Immunological response and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13 12 (1995) 1123-1130
6. Claassen E., De Leeuw W., De Greeve P., Hendriksen C., and Boersma W. Freund's complete adjuvant: an effective but disagreeable formula. Res. Immunol. 143 5 (1992) 478-483
7. Corbeil L.B. Antibodies as effectors. Vet. Immunol. Immunopathol. 87 3/4 (2002) 169-175
8. De Oliveira Mendes C., Paraguai de Souza E., Borja-Cabrera G.P., Maria Melo Batista L., Aparecida dos Santos M., Ellner Parra L., Menz I., Palatnik M., and Palatnik de Sousa C.B. IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis. Vaccine 21 19/20 (2003) 2589-2597
9. Eggimann P., Garbino J., and Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3 11 (2003) 685-702
10. Ekkel E.D., Kuypers A.H., Counotte G.H.M., and Tielen M.J.M. The phytohaemagglutinin (PHA) skin test as an indicator of stress-induced changes in immune reactivity in pigs. Vet. Q. 17 (1995) 143-146
11. Estes D.M., and Brown W.C. Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet. Immunol. Immunopathol. 90 1-2 (2002) 1-10
12. Gogolewski R.P., Kania S.A., Liggitt H.D., and Corbeil L.B. Protective ability of antibodies against 78- and 40-kilodalton outer membrane antigens of Haemophilus somnus. Infect. Immun. 56 9 (1988) 2307-2316
13. Hernández A., Karrow N., and Mallard B.A. Evaluation of immune responses of cattle as a means to identify high or low responders and use of a human microarray to differentiate gene expression. Genet. Sel. Evol. 35 Suppl. 1 (2003) S67-81
14. Hernández A., Yager J.A., Wilkie B.N., Leslie K.E., and Mallard B.A. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants. Vet. Immunol. Immunopathol. 104 1/2 (2005) 45-58
15. Hohl T.M., Rivera A., and Pamer E.G. Immunity to fungi. Curr. Opin. Immunol. 18 4 (2006) 465-472
16. Hurvich C.M., and Tsai C.-L. Selection of a multistep linear predictor for short time series. Stat. Sin. 7 (1997) 395-406
17. Kensil C.R., Patel U., Lennick M., and Marciani D. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146 (1991) 431-437
18. Kobayashi K., Kaneda K., and Kasama T. Immunopathogenesis of delayed-type hypersensitivity. Microsc. Res. Technol. 53 4 (2001) 241-245
19. Linghua Z., Yong G., Xingshan T., and Fengzhen Z. Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo. Dev. Comp. Immunol. 30 6 (2006) 589-596
20. Liu L., Kang K., Takahara M., Cooper K.D., and Ghannoum M.A. Hyphae and yeasts of Candida albicans differentially regulate interleukin-12 production by human blood monocytes: inhibitory role of C. albicans germination. Infect. Immun. 69 7 (2001) 4695-4697
21. Mallard B.A., Wilkie B.N., Kennedy B.W., and Quinton M. Use of estimated breeding values in a selection index to breed Yorkshire pigs for high and low immune and innate resistance factors. Anim. Biotechnol. 3 2 (1992) 257-280
22. Mallard B.A., and Wilkie B.N. Selection experiments to alter disease resistance traits in domestic animals. Vet. Immunol. Immunopathol. 38 (1993) 387-394
23. Mallard B.A., Wilkie B.N., Kennedy B.W., Gibson J., and Quinton M. Immune responsiveness in swine: eight generations of selection for high and low immune response in Yorkshire pigs. Proceedings of the 6th World Congress. Genet. Appl. Livest. Prod. 27 (1998) 257
24. Matsumoto K., Yoshikawa H., Yasugi T., Nakagawa S., Kawana K., Nozawa S., Hoshiai H., Shiromizu K., Kanda T., and Taketani Y. Balance of IgG subclasses toward human papillomavirus type 16 (HPV16) L1-capsids is a possible predictor for the regression of HPV16-positive cervical intraepithelial neoplasia. Biochem. Biophys. Res. Commun. 258 1 (1999) 128-131
25. Mbulaiteye S.M., Gold B.D., Pfeiffer R.M., Brubaker G.R., Shao J., Biggar R.J., and Hisada M. H. pylori-infection and antibody immune response in a rural Tanzanian population. Infect. Agent Cancer 1 3 (2006) 1-7
26. McInerney T.L., Brennan F.R., Jones T.D., and Dimmock N.J. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide. Vaccine 17 11/12 (1999) 1359-1368
27. Moingeon P., Haensler J., and Lindberg A. Towards the rational design of Th1 adjuvants. Vaccine 19 (2001) 4363-4372
28. Pinard M.H., van Arendonk J.A., Nieuwland M.G., and van der Zijpp A.J. Divergent selection for immune responsiveness in chickens: estimation of realized heritability with an animal model. J. Anim. Sci. 70 10 (1992) 2986-2993
29. Puel A., Mevel J.-C., Bouthillier Y., Feingold N., and Fridman W.H. Towards genetic dissection of high and low antibody responsiveness in Biozzi mice. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 14742-14746
30. Rogers A.S., Ellenberg J.H., Douglas S.D., Henry-Reid L., Peralta L., and Wilson C.M. Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with human immunodeficiency virus. Clin. Diagn. Lab. Immunol. 8 2 (2001) 273-278
31. Rothel J.S., Corner L.A., Lightowlers M.W., Seow H.F., McWaters P., Entrican G., and Wood P.R. Antibody and cytokine responses in efferent lymph following vaccination with different adjuvants. Vet. Immunol. Immunopathol. 63 1-2 (1998) 167-183
32. ® User's Guide, Version 9.1 (1999), SAS Institute Inc., Cary, NC 3884 pp.
33. Shook G.E. Selection for disease resistance. J. Dairy Sci. 72 5 (1989) 1349-1362
34. Sokal R.R., and Rohlf F.J. Biometry. third ed. (1995), W.H. Freeman and Co, NY 887 pp
35. Spickler A.R., and Roth J.A. Adjuvants in veterinary vaccines: modes of action and adverse effects. J. Vet. Intern. Med. 17 3 (2003) 273-281
36. Stewart-Tull D.E.S. The Theory and Practical Application of Adjuvants (1994), John Wiley & Sons 380 pp
37. Sun H.X., Ye Y.P., Pan H.J., and Pan Y.J. Adjuvant effect of Panax notoginseng saponins on the immune responses to ovalbumin in mice. Vaccine 22 29/30 (2004) 3882-3888
38. Tuite A., Mullick A., and Gros P. Genetic analysis of innate immunity in resistance to Candida albicans. Genes Immun. 5 7 (2004) 576-587
39. Wagter L.C., Mallard B.A., Wilkie B.N., Leslie K.E., Boettcher P.J., and Dekkers J.C.M. A quantitative approach to classifying Holstein cows based on antibody responsiveness and its relationship to peripartum mastitis occurrence. J. Dairy Sci. 83 (2000) 488-498
40. Welsh M.D., Cunningham R.T., Corbett D.M., Girvin R.M., McNair J., Skuce R.A., Bryson D.G., and Pollock J.M. Influence of pathological progression on the balance between cellular and humoral immune responses in bovine tuberculosis. Immunology 114 1 (2005) 101-111
41. Wilkie B.N., Mallard B.A., Quinton M., and Gibson J. Multi-trait selection for immune response: a possible alternative strategy for enhanced livestock health and productivity. Prog. Pig. Sci. (1998) 29-38
42. Zhang L., Tian X., and Zhou F. CpG oligodeoxynucleotides augment the immune responses of piglets to swine Pasteurella multocida living vaccine in vivo. Res. Vet. Sci. 83 2 (2007) 171-181
43. Zessin K.H. Emerging diseases: a global and biological perspective. J. Vet. Med. B: Infect. Dis. Vet. Public Health 53 Suppl. 1 (2006) 7-10